Alembic Revenue and Competitors
Estimated Revenue & Valuation
- Alembic's estimated annual revenue is currently $5.6M per year.
- Alembic's estimated revenue per employee is $121,043
- Alembic's total funding is $39M.
Employee Data
- Alembic has 46 Employees.
- Alembic grew their employee count by 48% last year.
Alembic's People
Name | Title | Email/Phone |
---|---|---|
1 | CTO/COO | Reveal Email/Phone |
2 | Founder & Chief Creative Officer | Reveal Email/Phone |
3 | Head Demand Generation | Reveal Email/Phone |
4 | VP Product (Head) | Reveal Email/Phone |
5 | VP Sales and Marketing | Reveal Email/Phone |
6 | Chief Innovation Officer | Reveal Email/Phone |
7 | Senior Director Media Strategy & Planning | Reveal Email/Phone |
8 | Director Operations | Reveal Email/Phone |
9 | Enterprise Account Executive | Reveal Email/Phone |
10 | Sr. Partner B2C & Brands | Reveal Email/Phone |
Alembic Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 87 | 14% | N/A | N/A |
What Is Alembic?
Alembic is a stealth phase startup that is developing cutting edge new technology.
keywords:N/A$39M
Total Funding
46
Number of Employees
$5.6M
Revenue (est)
48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alembic News
2022-04-20 - Alembic gets USFDA nod to market generic drug - Jammu ...
Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market lvabradine tablets, used to treat...
2022-04-20 - Alembic gets USFDA nod to market generic drug
Alembic said it has now received a cumulative total of 164 ANDA approvals (140 final approvals and 24 tentative approvals) from the USFDA...
2022-04-20 - Alembic Gets USFDA Nod To Market Ivabradine Used In ...
Alembic said it has now received a cumulative total of 164 ANDA approvals (140 final approvals and 24 tentative approvals) from the USFDA...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.1M | 46 | 0% | $27M |
#2 | $3.5M | 46 | 5% | N/A |
#3 | $7.7M | 46 | -28% | N/A |
#4 | $6.1M | 46 | N/A | N/A |
#5 | $5.3M | 46 | N/A | N/A |